GSK/Sanofi booster delayed by lack of uninfected people to test it on
in older people. Sanofi has developed the antigen, the substance that induces the immune system to produce antibodies against it, and GSK is contributing its adjuvant, a substance that boosts the vaccine’s immune response.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Emma Raducanu tests positive for Covid-19, jeopardising Australian Open preparationsEmma Raducanu's preparations for next month’s Australian Open have been derailed after she tested positive for Covid-19
Consulte Mais informação »
Covid: Norwich students say booster jabs remove fear of infecting othersNorwich students say boosters remove fear of infecting others and want their jabs before going home for Christmas
Consulte Mais informação »
What is the difference between NHS and government Covid alert levels?NHS system is based on centrally-agreed list of definitions, whereas government’s system has five stages based on variety of factors
Consulte Mais informação »
NHS overwhelmed after millions answer call for Covid booster jabsThe NHS was scrambling to deliver government pledges on booster jabs as millions of people answered calls to get the vaccines
Consulte Mais informação »